Seeking healthy volunteers aged 18 and older for a study of an experimental flu vaccine.
Participants in this study will receive either the experimental flu vaccine or the standard flu vaccine. Participants will have study visits at 4 weeks and 6 months following vaccination. Participants are asked not to get another flu vaccine for the 6 months they are in the study.
What we're hoping for
We are studying whether an experimental flu vaccine made with the type of MRNA technology used to develop the COVID vaccine is safe and effective in preventing influenza compared to the standard flu vaccine.
ClinicalTrials.gov Identifier: NCT05540522